Zhejiang Hisun Pharmaceutical Co., Ltd. (600267)

Overview

Zhejiang Hisun Pharmaceutical Co., Ltd. stands as a prominent entity in the pharmaceutical domain, focusing on the research, development, production, and sale of biological and generic drugs primarily within China. Initiated in 1956, the company has established a significant presence in the pharmaceutical industry, showcasing a robust portfolio that caters to a variety of medical needs. Headquartered in Taizhou, China, Hisun Pharmaceutical not only dominates the local market but also marks its presence on a global scale, exporting products to approximately 70 countries worldwide. The company’s dedication to innovation and quality in healthcare solutions propels its reputation and expansion across a diversified customer base.

Products and Services

Zhejiang Hisun Pharmaceutical Co., Ltd.'s product offerings encompass a wide range of medical treatments and healthcare solutions, articulated as follows:

• Anti-tumor: Specializing in the production of drugs aimed at combating various forms of cancer, assisting in the reduction of tumor growth and providing patients with hope and improved quality of life.
• Anti-infection: Offering an extensive array of antibiotics and other medication designed to fight infectious diseases and prevent the spread of infections.
• Cardiovascular: Developing medications that aid in the treatment, management, and prevention of heart diseases and conditions affecting the cardiovascular system.
• Endocrine: Producing drugs that help in regulating hormonal imbalances, catering to disorders related to the endocrine system.
• Immunosuppression: Offering treatments that modulate the immune system, crucial for patients undergoing organ transplants and those with autoimmune diseases.
• Antidepressant: Developing medications to help manage and treat various forms of depression, improving the mental health and well-being of patients.
• Liver care: Providing products specifically aimed at the treatment and maintenance of liver health, addressing a range of liver conditions.
• Orthopaedics: Catering to the field of orthopedics with medications and solutions for bone health, joint care, and recovery from musculoskeletal injuries.
• Weight loss: Offering medications aimed at assisting with weight management, promoting healthier life choices and combatting obesity.
• Anti-viral: Developing antiviral drugs that serve a critical role in the treatment of viral infections, including those caused by novel pathogens.
• Anti-TB: Providing treatment solutions for tuberculosis, a leading infectious disease, with an aim to contribute to global TB eradication efforts.
• Animal healthcare: Extending its expertise to the veterinary field, with products aimed at ensuring the health and well-being of animals.

All these products and services underscore Hisun Pharmaceutical's commitment to advancing healthcare and improving lives through innovative and effective pharmaceutical solutions.